TCNNF - CIK 0001754195
Trulieve Cannabis Corp. trades as TCNNF. In its fiscal 2025 annual report the company posted revenue of $1.18B, down 0.4% from the prior year and net income of -$116.38M. This page tracks Trulieve Cannabis Corp. through 393 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 6 fiscal years Trulieve Cannabis Corp.'s revenue grew from $252.82M to $1.18B, a compound annual growth rate of 29.3%. Net profit margin compressed from 21.0% to -9.9% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
| Proxy materials | DEFA14A | 2026-04-29 |
| Annual report to shareholders | ARS | 2026-04-29 |
| Proxy statement | DEF 14A | 2026-04-29 |
| Major company event | 8-K | 2026-04-21 |
| Insider trade | 4 | 2026-03-17 |
| Insider trade | 4 | 2026-03-17 |
The largest companies sharing Trulieve Cannabis Corp.'s SEC industry classification (medicinal chemicals & botanical products).
Trulieve Cannabis Corp. reported revenue of $1.18B for fiscal year 2025, a decrease of 0.4% year over year.
In its latest fiscal year Trulieve Cannabis Corp. reported a net loss of $116.38M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.